SCHEMBL26778908

SCHEMBL26778908

c1ccc(-c2ccc(N(c3ccccc3)c3cccc4oc5cc(-c6nc(-c7ccccc7)nc(-c7ccc8ccccc8c7)n6)ccc5c34)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.38
MEN1 O00255 2/20 0.38
ALDH1A1 P00352 2/20 0.38
KMT2A Q03164 2/20 0.38
HSD17B10 Q99714 2/20 0.38
KDM4E B2RXH2 1/20 0.38
TP53 P04637 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CCR4 P51679 1/20 0.32
NOTUM Q6P988 1/20 0.32
CYP1A1 P04798 2/20 0.31
CYP1B1 Q16678 2/20 0.31
PGR P06401 1/20 0.31
PTGES O14684 1/20 0.31
ALOX5 P09917 1/20 0.31
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
AHR P35869 1/20 0.31
UTRN P46939 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25978388 1.00 CYP1A2 (0.38) CYP1A2MEN1ALDH1A1KMT2AHSD17B10
SCHEMBL25978512 0.99 CYP1A2 (0.37) CYP1A2MEN1ALDH1A1KMT2AHSD17B10
SCHEMBL26778914 0.99 CYP1A2 (0.36) CYP1A2MEN1ALDH1A1KMT2AHSD17B10
SCHEMBL26778634 0.96 MEN1 (0.35) CYP1A2MEN1ALDH1A1KMT2AHSD17B10
SCHEMBL25977956 0.96 MEN1 (0.35) CYP1A2MEN1ALDH1A1KMT2AHSD17B10
SCHEMBL25978446 0.95 CYP1A1 (0.39) CYP1A2MEN1ALDH1A1KMT2AHSD17B10
SCHEMBL26778644 0.94 KMT2A (0.33) CYP1A2MEN1ALDH1A1KMT2AHSD17B10
SCHEMBL25978390 0.94 KMT2A (0.33) CYP1A2MEN1ALDH1A1KMT2AHSD17B10
SCHEMBL26778684 0.94 KMT2A (0.33) CYP1A2MEN1ALDH1A1KMT2AHSD17B10
SCHEMBL25978370 0.94 KMT2A (0.33) CYP1A2MEN1ALDH1A1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 CYP1A2 5/4885MEN1 257/4885ALDH1A1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.